Get Healthy!

Results for search "Immunization".

Health News Results - 197

Use Facebook a Lot? You're More Likely to Be Unvaccinated

Americans who get their COVID-19 news and information solely from Facebook have much lower vaccination rates than the general population.

That's the takeaway from a new survey of nearly 20,700 people across the United States. The researchers asked them in June which of six sources they use for COVID-19 news and info. The six included: Facebook, CNN, Fox News, MSNBC, the Biden administrati...

Survey Finds U.S. Parents Split on COVID Vaccination for Kids Under 12

As a new school year approaches, U.S. parents are nearly evenly split on whether they'll vaccinate their young kids when a COVID-19 vaccine is approved for their age group, a new survey finds.

"It's important that parents and providers don't wait for full COVID vaccine approval to begin discussions about vaccination," said Sarah Clark, co-director of the C.S. Mott Children's Hospital Nati...

Secret Weapon: Why the 2nd Dose of Pfizer Vaccine Is So Crucial

It takes two doses of the Pfizer-BioNTech COVID-19 vaccine to "wake up" cells that play a very important role in the body's immune response, with the second dose increasing their numbers 100-fold, according to new research.

The Stanford University study may help explain why getting the second dose of mRNA vaccines, such as the Pfizer or Moderna shots, is so crucial to building a strong im...

CDC Advisors to Discuss 3rd COVID Vaccine Dose for Immunocompromised

Giving a third dose of COVID-19 vaccines to adults with weakened immune systems — the immunocompromised — will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.

At the meeting scheduled for July 22, the Advisory Committee on Immunization Practices will focus on the 2% to 4% of U.S. adults with weakened immune systems. These...

COVID Antibodies From Vaccination Are Almost 3 Times Higher Than From Infection

THURSDAY, July 15, 2021 (HealthDay News) -- People who've been fully vaccinated against COVID-19 have a much stronger immune system response against the new coronavirus than those who've previously been infected, according to a new study.

"Vaccinated individuals had the highest antibody levels, nearly three times higher than that of convalescent individuals recovering f...

Inhaled COVID Vaccine Shows Promise in Animal Trials

Breathing in protection: Scientists say an experimental inhaled COVID-19 vaccine shows promise in animal tests.

"The currently available vaccines against COVID-19 are very successful, but the majority of the world's population is still unvaccinated and there is a critical need for more vaccines that are easy to use and effective at stopping disease and transmission," said study co-leader ...

She Got Her Shots and Is Helping Other Seniors Rejoin Society

Before the COVID-19 pandemic, Sandra Banner was an active octogenarian. She enjoyed going to movies, traveling from her Palm Desert, Calif., home to Los Angeles for Dodgers baseball games and having friends over for happy hours.

Early on, she avoided isolation by teaching outdoor tai chi classes and staying engaged online, but once she was fully vaccinated, Banner, 85, was ready to get ba...

Black Churches Could Be Key to Boosting Vaccination Rates

Black churches could prove crucial in improving COVID-19 vaccination rates among Black Americans, a new study suggests.

The COVID-19 death rate among Black Americans is three times higher than among white Americans, and health officials had hoped that vaccines would narrow that gap.

However, Black communities are disproportionately affected by barriers to vaccination, such as limite...

Chinese CoronaVac Vaccine 83.5% Effective Against Symptomatic COVID

A double dose of China's CoronaVac vaccine is 83.5% effective against symptomatic COVID-19, researchers say.

Their phase 3 trial included more than 10,000 people, aged 18 to 59, in Turkey who received either two doses of CoronaVac 14 days apart or an inactive placebo.

An immune response analysis of 981 participants who got the vaccine found that it triggered a strong immune response...

Rare 'Breakthrough' COVID Infections in Vaccinated Are Milder: Study

Folks who suffer a rare "breakthrough" coronavirus infection after getting the Pfizer or Moderna vaccine will not get as sick and, importantly, are much less likely to pass the coronavirus on to others, a new study shows.

It's very unlikely that a person will become infected with COVID-19 after getting one of the messenger RNA (mRNA) vaccines, which provided 91% effective protection among...

Some Myeloma Patients Get No Protection From COVID-19 Vaccines

Because they're often given drugs that suppress their immune systems, people battling a blood cancer known as multiple myeloma have varying responses to the COVID-19 vaccine, new research shows.

Some patients had no evidence at all of COVID-fighting antibody production after getting two doses of vaccine, the new study found.

In a minority of cases, fully vaccinated myeloma patients ...

Pfizer, Moderna Vaccines May Stand Guard Against COVID for Years

The Pfizer and Moderna vaccines trigger an immune system response that could fend off the coronavirus for years to come, new research reveals.

The latest study bolsters growing evidence that most people immunized with the mRNA vaccines may not need booster shots, with one key caveat: That the virus and its variants don't evolve too much beyond the virus' original form.

"It's a good...

Third Dose of COVID Vaccine Boosts Protection in Transplant Recipients

Researchers say an extra dose of two-dose COVID-19 vaccines may improve immune system protection for organ transplant patients, a group that's so far responded poorly to two-dose vaccines.

"Our findings suggest clinical trials are warranted to determine if transplant recipients should receive COVID-19 vaccine booster doses as standard clinical practice, similar to what is currently done w...

Babies Produce Strong Immune Response to Ward Off COVID-19: Study

British researchers report that babies have a strong immune response to the virus that causes COVID-19, based on a new, small study.

For the research, the investigators assessed the immune systems of four infants under 3 months of age who had recovered from COVID, and compared them with adults who also had recovered from the disease.

Compared to adults, the babies produced relative...

There Are Many Good Reasons for Kids to Get the COVID Vaccine

Parents need to know that COVID-19 shots are safe and effective for kids age 12 and older, an expert says.

While the Pfizer vaccine is approved in the United States for emergency use in this age group, parents may need reassurance, said Dr. Jessica Ericson, an infectious disease pediatrician at Penn State Health Children's Hospital in Hershey.

"The vaccines went through rigorous stu...

Obesity Could Raise Odds for 'Long-Haul' COVID Symptoms

If you're obese, you're far more likely to have long-lasting health issues if you get COVID-19 and survive, a new study warns.

You are more likely than patients who aren't obese to be hospitalized. You're more likely wind up in the intensive care unit, need to be put on a ventilator and suffer from long-haul COVID than patients who aren't obese, researchers reported.

"About 40% of C...

Will People Really Need a Yearly COVID Booster Vaccine?

As the number of people fully immunized against COVID-19 rises into the hundreds of millions, immunologists and infectious disease experts now are pondering a new question in the unfolding pandemic.

Namely, how long will vaccine immunity last, and will people who've gotten the jab need booster shots to maintain their protection?

It's an important question, as waning immunity in the ...

Real-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVID

A real-world study shows that even when folks who get the Pfizer and Moderna COVID-19 vaccines do have 'breakthrough' infections, those illnesses are mild.

The study, from researchers at the U.S. Centers for Disease Control and Prevention, is among the first to show that people who get COVID-19 despite being fully or partially vaccinated are less likely to have serious illness or to infec...

'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant Patients

New research suggests that many people who've undergone an organ transplant do not get an immune response from COVID-19 vaccines that's strong enough to ward off a "breakthrough" infection.

In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and one heart recipient, said a research team...

Teens: You Got Your COVID Vaccine, What Now?

U.S. teens are getting their COVID shots -- how does that change their daily lives?

Besides letting teens resume many of their normal activities, U.S. authorization of the Pfizer COVID-19 vaccine for people as young as 12 is crucial to slowing the spread of the coronavirus, one expert says.

"We know that teenagers can not only get COVID-19 but they can also transmit the virus,"...

Prior COVID Infection May Shield You From Another for at Least 10 Months

In some good news for those who have already suffered through a bout of COVID-19, a new study finds they may have a much lower risk of reinfection for at least 10 months.

For the study, the researchers analyzed rates of SARS-CoV-2 infections between October 2020 and February 2021 among more than 2,000 nursing home residents (median age 86) and staff. Antibody testing was used to determine...

NIH Starts Trial Assessing 'Mix & Match' COVID Vaccine Approach

Moderna plus Pfizer? J&J plus Moderna? There's a new clinical trial underway to assess the safety and effectiveness of mixing different types of booster shots in adults who have been fully vaccinated against COVID-19.

"Although the vaccines currently authorized by the U.S. Food and Drug Administration offer strong protection against COVID-19, we need to prepare for the possibility of ne...

As Teen He Made News Opposing Anti-Vax Mom. Now, He's Urging COVID Shots for Youth

Ethan Lindenberger knows what it's like when you have anti-vaxxer parents: At 18, he gained national notoriety when he sought vaccines in defiance of his mother's fervent wishes.

Now, the 20-year-old has some advice for teens facing a similar dilemma posed by the pandemic -- how to convince their anti-vaxxer parents to let them get the COVID-19 vaccine.

The Pfizer shot is now FDA--a...

Debunking Myths That Have Some Parents Resisting COVID Vaccines for Teens

Many health experts hailed the recent approval of the Pfizer vaccine for those aged 12 to 15, but some parents have been hesitant to take their kids in for a shot.

"Parents naturally worry more about their children than they do about themselves -- I think that's parenting defined," said Dr. Hina Talib, a pediatrician and adolescent health specialist at the Children's Hospital at Montefior...

Another Study Finds Routine Vaccines Safe for Kids, Adults

If more proof of the safety of vaccines is needed, a new study delivers fresh evidence that they carry few harms for children, adults and pregnant women.

"This in-depth analysis found no evidence of increased risk of serious adverse events following vaccines, apart from a few - previously known - associations," said Susanne Hempel, director of the Southern California Evidence Review Cente...

Common Immune Drug Methotrexate May Hamper Response to COVID-19 Vaccine

A widely used medicine for autoimmune diseases may lower people's immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests.

The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis.

"Our findings suggest that different strategies may need to be explored in pa...

Many Americans Take Meds That Weaken COVID Vaccine Response

A small but significant percentage of Americans take medications that can hamper their immune system and its response to COVID-19 vaccines, researchers say.

Their analysis of data from more than 3 million adults under 65 with private insurance found that nearly 3% take immunosuppressive drugs. Those include chemotherapy medications and steroids such as prednisone.

Two-thirds took an...

Dialysis Patients Have Weaker Response to COVID Vaccine: Study

A single dose of a COVID-19 vaccine isn't enough to develop adequate antibodies in kidney dialysis patients, Canadian researchers report.

"We advise that the second dose of the [Pfizer] vaccine be administered to patients receiving hemodialysis at the recommended 3-week time interval and that rigorous SARS-CoV-2 infection prevention and control measures be continued in hemodialysis units ...

Two Out of Three California Prison Inmates Said Yes to COVID Vaccine

Sixty-seven percent of inmates in California prisons who were offered a COVID-19 vaccine have accepted at least one dose, a Stanford University study found.

"This is one of the largest state prison systems in the country, and if it can achieve high vaccination coverage among its incarcerated population, then the federal and other state prisons systems can and should do the same for the mo...

Israel Study: Pfizer Vaccine Gives 95% Protection Against Illness, Hospitalization & Death

Two doses of the Pfizer-BioNTech COVID-19 vaccine provide a high level of protection for populations, a new study shows.

The findings from Israel -- the first nation to report national data on the vaccine -- show that two doses provide more than 95% protection for people 16 and older against COVID-19 infection, hospitalization and death.

The study period was from Jan. 24 to April 3,...

U.S. COVID Outlook Shows Big Improvement by July

The United States could see a sharp decline in COVID-19 cases by the end of July, according to a new report from the U.S. Centers for Disease Control and Prevention.

Six research teams asked to project future COVID-19 trends have concluded that new infections will drastically drop in July and continue to fall through September, the researchers reported May 5 in the Morbidity and Morta...

Not Just About Antibodies: Why mRNA COVID Vaccines May Shield From Variants

Two widely used COVID-19 vaccines -- Pfizer and Moderna -- will likely remain powerfully protective against developing serious illness even if coronavirus variants somehow manage to infect vaccinated patients, new research suggests.

Both vaccines are based on messenger RNA (mRNA) technology. And investigators say that, at least in theory, such technology can deploy multiple levels of defe...

Needle Anxiety Behind J&J COVID Vaccine Reaction Clusters: Study

Anxiety was the cause of 64 vaccine reactions, including fainting, in people who got the Johnson & Johnson single-dose COVID-19 vaccine in early April at sites in five states, a new study finds.

Researchers led by Anne Hause of the U.S. Centers for Disease Control and Prevention noted that "anxiety-related events, including syncope [fainting], can occur immediately after vaccination with ...

1 in 5 Patients on Kidney Dialysis Say No to COVID-19 Vaccine: Study

About 20% of Americans on kidney dialysis are reluctant to get a COVID-19 shot, according to a new study.

Kidney failure patients on dialysis are at increased risk for COVID-related complications that could lead to hospitalization and death, so it's important for them to be vaccinated, researchers said.

"Finding that 80% of patients on dialysis were willing to get a COVID-19 vaccine...

Poll Reveals Who's Most Vaccine-Hesitant in America and Why

U.S. resistance to getting a COVID-19 vaccine is slowly diminishing, a new online survey finds, but it still exists and at especially rates in some blue-collar jobs.

For adults under age 65 who are hesitant, reluctance is mainly driven by concerns about safety, side effects and distrust in government, the poll found. It's also largely linked to people's line of work.

The bottom line...

Pfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at Second

There's some sobering news for the millions of Americans who skipped their second coronavirus vaccine dose: Doing so could greatly reduce their odds of avoiding severe illness.

In a "real-world" study of 417 adults aged 65 or older who got either the Pfizer or Moderna two-dose vaccines, effectiveness in keeping folks out of the hospital with COVID-19 "was 94% among adults who were fully v...

Is a Cheap 'Universal' Coronavirus Vaccine on the Way?

An experimental COVID-19 vaccine could potentially provide universal protection against future COVID variants as well as other coronaviruses -- maybe even the ones responsible for the common cold. And it's dirt cheap -- less than $1 a dose, researchers say.

The vaccine targets a part of the COVID virus' spike protein that appears to be highly resistant to mutation and is common across nea...

They're on the Frontlines of the U.S. Vaccine Rollout

THURSDAY, April 22, 2021 (HeathDay News) -- April 16 was the first day that any Californian aged 16 or older became eligible to get the COVID-19 vaccine.

And at a bustling vaccination center in Pomona, Calif., 16-year-old Ashley Madera was in line to get her first dose of the Pfizer vaccine.

"I think that this vaccine is effective," said Madera, who lives in nearby Rancho Cucamonga...

Rashes Can Occur After COVID Vaccine, But Dermatologists Say 'Don't Worry'

Dermatologists liken skin to a window that can reveal what is going on inside the body, and a rash that sometimes follows a COVID-19 vaccine is one example.

When you get the shot, your immune system activates, preparing to recognize and fight off the virus in the future. This response and the inflammation that goes with it can occasionally result in a rash. But experts say as long as it h...

Most Young Americans Eager to Get COVID Vaccine: Poll

Many American teens and young adults are now embracing the chance to get COVID-19 vaccines, a new survey finds.

But youth-focused messaging will still be needed to convince a minority of those aged 14 to 24 that they should be vaccinated, the University of Michigan researchers said. Still, the good news is that more young people are ready to get their shots than said they were ready to do...

Had Facial Fillers? What You Need to Know About COVID Vaccines

Once you've landed that coveted coronavirus vaccine appointment, you'll likely have to fill out a form on your medical history and whether you're allergic to any of the vaccine's ingredients. But there could be another question waiting for you: Have you ever had dermal filler injections?

That's because -- in rare cases -- people who've had the face-plumping injections can develop a mild, ...

NIH Starts Trial Looking at Rare Allergic Reactions to COVID Vaccines

A new clinical trial will investigate whether people who are highly allergic or have what's known as a mast cell disorder are at higher risk for a sudden allergic reaction to the Moderna or Pfizer COVID-19 vaccines.

"The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines," said Dr. Anthony Fauci, d...

No Proof COVID Vaccines Can Trigger Guillain-Barré Syndrome

Two people in the Johnson & Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it's highly doubtful the vaccine is to blame, according to a just-published case study.

Although both people were in the same trial, one was given the vaccine and the other was given a placebo of saline solution.

"That strengthens the possibility that the case in our report may have be...

Moderna COVID Vaccine Offers Protection for at Least 6 Months: Study

There's good news for the millions of Americans who've already received a dose or two of Moderna's COVID-19 vaccine: New research shows the vaccine should protect against illness for at least six months.

The new study tracked 33 participants in the trials that led to the vaccine's approval. Six months after having received their second vaccine dose, "antibody activity remained high in al...

If You've Had COVID, One Vaccine Jab Will Do: Study

A new U.S. study offers more evidence that a single dose of a two-dose COVID-19 vaccine may provide enough protection to people who've previously been infected with the coronavirus.

"Our findings extend those from smaller studies reported elsewhere and support a potential strategy of providing a single dose of vaccine to persons with a confirmed prior history of coronavirus infection, al...

Got Your COVID Vaccine? Don't Stop Being Cautious, Experts Say

Just because you've had your COVID-19 vaccination doesn't mean you can stop taking steps to protect yourself and others, experts say.

So far, only about 16% of Americans have been fully vaccinated, and on March 24, the U.S. Centers for Disease Control and Prevention reported a 6.7% increase in the seven-day average number of daily cases, compared to the prior week.

About 60,000 peo...

When Will America's Kids Get Their COVID Vaccines?

Kids will be kids, and that's exactly why Holly McDade plans to get her three young children the COVID-19 vaccine as soon as it becomes available to them.

"Little kids can't help but touch their mouths and their noses and touch other things," said McDade, 32, of Strasburg, Va. "They just don't think about it. It's not where their brains are at yet."

McDade isn't concerned so much ab...

1 in 4 Parents Won't Vaccinate Their Kids Against COVID-19: Poll

More than one-quarter of U.S. parents don't plan to vaccinate their kids for COVID-19, and roughly as many oppose school-required coronavirus shots, a new study finds.

This opposition was more common among moms than dads, and was especially common among white mothers who identified as Republican/Republican-leaning, the researchers said.

"Women tend to serve as family health managers...

Can Vaccinations Stop COVID Transmission? College Study Aims to Find Out

It's the question everyone wants answered because reopening the world depends on it: Can coronavirus vaccines stop transmission of the virus?

Now, 21 universities across the United States are teaming up to find out.

The project, called Prevent COVID U, was started by the COVID-19 Prevention Network housed at the Fred Hutchinson Cancer Research Center in Seattle.

The study inc...

HPV Infections Are Plummeting Due to Widespread Vaccination

Fifteen years of widespread vaccination of U.S. children with the human papillomavirus (HPV) vaccine is reaping big rewards: A more than 80% drop in new infections has been seen in women and girls under the age of 25.

That could mean an equally big drop to come in a host of dangerous conditions that are linked to HPV infection, including cancers of the cervix, anogenital area and mouth/th...